Financials data is unavailable for this security.
View more
Year on year AbbVie Inc had little change in net income (from 4.28bn to 4.23bn) despite revenues that grew 8.57% from 56.33bn to 61.16bn.
| Gross margin | 71.16% |
|---|---|
| Net profit margin | 4.02% |
| Operating margin | 15.16% |
| Return on assets | 1.73% |
|---|---|
| Return on equity | 138.53% |
| Return on investment | 2.46% |
More ▼
Cash flow in USDView more
In 2024, cash reserves at AbbVie Inc fell by 7.29bn. However, the company earned 18.81bn from its operations for a Cash Flow Margin of 33.38%. In addition the company used 20.82bn on investing activities and also paid 5.21bn in financing cash flows.
| Cash flow per share | 6.08 |
|---|---|
| Price/Cash flow per share | 35.98 |
| Book value per share | -1.49 |
|---|---|
| Tangible book value per share | -52.39 |
More ▼
Balance sheet in USDView more
SmartText is unavailable
| Current ratio | 0.7245 |
|---|---|
| Quick ratio | 0.5992 |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | 1.04 |
More ▼
Growth rates in USD
SmartText is unavailable
| Div yield(5 year avg) | 3.98% |
|---|---|
| Div growth rate (5 year) | 8.00% |
| Payout ratio (TTM) | 496.51% |
| EPS growth(5 years) | -14.67 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -53.76 |
More ▼
